Exosome Therapeutics Market Report 2025: 120+ Drug Candidates in Pipeline, Market to Reach $1.4 Billion by 2040, Growing at 41.1% CAGR [Yahoo! Finance]
Coya Therapeutics, Inc. (COYA)
Company Research
Source: Yahoo! Finance
offer benefits in tissue regeneration, inflammation reduction, and targeted drug delivery, driving demand across oncology, dermatology, musculoskeletal, and ophthalmic disorders. With 120+ therapeutic candidates in development and $570 million in investments, the market is set for rapid expansion. Asia-Pacific is expected to dominate market share, with retinitis pigmentosa and cancer applications growing fastest. Exosome Therapeutics Market Exosome Therapeutics Development Pipeline Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Exosome Therapeutics Market Industry Trends and Global Forecasts to 2035, by Type of Therapeutic, Target Indication, Therapeutic Area, Route of Administration and Geography" report has been added to ResearchAndMarkets.com's offering. The global exosome therapy is estimated to grow from USD 0.03 billion in 2029 to USD 1.4 billion by 2040, at a CAGR of 41.1% during the forecast period, till 2035. Owing to the various benefits, such as enhanced tissue r
Show less
Read more
Impact Snapshot
Event Time:
COYA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COYA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COYA alerts
High impacting Coya Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
COYA
News
- Coya Therapeutics (NASDAQ:COYA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.MarketBeat
- Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA 302 for the Treatment of ALSBusiness Wire
- Coya Therapeutics to Participate in Upcoming Investor Relations and Clinical Trials Conferences [Yahoo! Finance]Yahoo! Finance
- ReAlta Life Sciences Appoints Dr. Howard Berman as Executive ChairmanBusiness Wire
- Coya Therapeutics to Participate in Upcoming Investor Relations and Clinical Trials ConferencesBusiness Wire
COYA
Earnings
- 11/12/25 - Miss
COYA
Sec Filings
- 11/12/25 - Form 10-Q
- 11/12/25 - Form 8-K
- 10/27/25 - Form 8-K
- COYA's page on the SEC website